| ANLN | Actin-binding protein |
| ALKBH5 | AlkB homolog 5 |
| AUC | Area under the ROC curve |
| PD-L1 | Programmed death-ligand 1 |
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 |
| DEGs | Differentially expressed genes |
| ECL | Enhanced chemiluminescence |
| EdU | Ethynyl-2′-deoxyuridine |
| FPKM | Fragments per kilobase of transcript per million mapped reads |
| FTO | Fat mass and obesity-associated protein |
| GAL-9 | Galectin-9 |
| GEO | Gene Expression Omnibus |
| HCC | Hepatocellular carcinoma |
| HNRNPC | Heterogeneous nuclear ribonucleoprotein C |
| HR | Hazard ratio |
| ICGC | International Cancer Genomics Consortium |
| ICIs | Immune checkpoint inhibitors |
| IPS | Immunophenotype score |
| LAG-3 | lymphocyte-activating 3 |
| LASSO | Least absolute shrinkage and selection operator |
| m6A | N6-methyladenosine |
| METTL | Methyltransferase-like |
| mRNAsi | mRNA stemness index |
| NK cells | Natural killer cells |
| OS | Overall survival |
| PCA | Principal component analysis |
| PDCD1 | Programmed cell death protein 1 |
| RBM15 | RNA-binding motif protein 15 |
| ROC | Receiver operating characteristic |
| shRNA | Short hairpin RNA |
| TCGA | The Cancer Genome Atlas |
| TIDE | Tumor immune dysfunction and exclusion |
| TIGIT | T cell immunoreceptor with Ig and ITIM domains |
| TIM-3 | T cell immunoglobulin and mucin-domain containing-3 |
| TMB | Tumor mutation burden |
| TPM | Transcripts per million kilobase |
| UMAP | Uniform Manifold Approximation and Projection |
| VIRMA | Vir-Like m6A Methyltransferase Associated protein |
| WTAP | Wilms tumor 1-associating protein |
| YTH | YT521-B homology |
| ZC3H13 | Zinc finger CCCH-type containing 13 |